Attention Training and Cognitive Therapy

This study has been completed.
Sponsor:
Information provided by:
University of Sydney
ClinicalTrials.gov Identifier:
NCT01093313
First received: March 24, 2010
Last updated: NA
Last verified: March 2010
History: No changes posted
  Purpose

The present study aimed to investigate the efficacy and process of change that occurs in Attention Training in comparison to an established treatment for social phobia, Cognitive Therapy. A randomized trial was conducted in which participants were allocated to either six weeks of Attention Training or Cognitive Therapy. It was hypothesized that both treatments would be effective in reducing social phobia symptoms, but that Attention Training would work primarily by reducing levels of self focused attention, while Cognitive Therapy would work through changes to probability and threat appraisals.


Condition Intervention
Social Phobia
Behavioral: Cognitive therapy
Behavioral: attention training

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Comparison of Attention Training and Cognitive Therapy in the Treatment of Social Phobia: a Randomized Controlled Trial

Resource links provided by NLM:


Further study details as provided by University of Sydney:

Enrollment: 46
Study Start Date: August 2006
Study Completion Date: March 2008
Primary Completion Date: April 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Attention training Behavioral: attention training
Active Comparator: Cognitive therapy Behavioral: Cognitive therapy

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years of age,
  • be fluent in English
  • have a primary concern of social anxiety that met DSM-IV criteria (APA, 2000) for social phobia. Both subtypes of social phobia, specific and generalized, were accepted into the study.

Exclusion Criteria:

  • the presence of comorbid condition(s) that were more severe than the presenting social phobia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01093313

Locations
Australia, New South Wales
The University of Sydney
Sydney, New South Wales, Australia, 2006
Sponsors and Collaborators
University of Sydney
Investigators
Principal Investigator: Maree Abbott, PhD The University of Sydney
  More Information

No publications provided

Responsible Party: Dr Maree Abbott, The University of Sydney
ClinicalTrials.gov Identifier: NCT01093313     History of Changes
Other Study ID Numbers: USydney9274
Study First Received: March 24, 2010
Last Updated: March 24, 2010
Health Authority: Australia: Human Research Ethics Committee

Additional relevant MeSH terms:
Phobic Disorders
Anxiety Disorders
Mental Disorders

ClinicalTrials.gov processed this record on April 16, 2014